News

Partner companies' news

SAB Biotherapeutics Appoints Mark J. Ratain, MD, to the Company’s Board of Scientific Advisors

Acorn Management Partners, Administrator
April 2022 — 460 views SABS

SAB Biotherapeutics Provides Company Update and Reports Full Year 2021 Financial Results

Acorn Management Partners, Administrator
April 2022 — 418 views SABS

Clinical Evaluation Finds Arch Therapeutics’ AC5® Advanced Wound System Effective in Healing Complex Chronic Wounds in Patients with Previously Unsuccessful Treatments and Significant Comorbidities

Acorn Management Partners, Administrator
January 2022 — 454 views ARTH

Arch Therapeutics Announces Appointment of Guy Fish to the Board

Acorn Management Partners, Administrator
January 2022 — 539 views ARTH

Arch Therapeutics Granted Federal Supply Schedule and General Supply Administration Contracts for AC5® Advanced Wound System

Acorn Management Partners, Administrator
December 2021 — 510 views ARTH

Arch Therapeutics Adds Key Opinion Leader Interview on Diabetic Foot Ulcers to the Experts in Wound Care Program

Acorn Management Partners, Administrator
December 2021 — 502 views ARTH

About us

Helping America invest in you:

Connecting your company stock with professional market participants.

One call at a time

Stay updated :

Participate on our social stream.

Our Blogs

Tags

Archives